Stroke and Falls-Clash of the Two Titans in Geriatrics
- PMID: 31022824
- PMCID: PMC6371176
- DOI: 10.3390/geriatrics1040031
Stroke and Falls-Clash of the Two Titans in Geriatrics
Abstract
Both stroke and falls are common conditions affecting the older adult. Despite stroke being considered a well-established major risk factor for falls, there remains no evidence for effective prevention strategies for falls specifically for stroke survivors. Previous observational studies evaluating falls risk factors in stroke have mainly been uncontrolled and found similar risk factors for stroke populations compared to general older populations. Specific risk factors, however, are likely to play a greater role in stroke survivors including unilateral weakness, hemisensory or visual neglect, impaired coordination, visual field defects, perceptual difficulties and cognitive issues. In addition, individuals with stroke are also more likely to have other associated risk factors for falls including diabetes, falls risk increasing drugs, atrial fibrillation, and other cardiovascular risk factors. While anticoagulation is associated with increased risk of intracranial bleeding after a fall, the risk of suffering a further stroke due to atrial fibrillation outweigh the risk of bleeding from a recurrent fall. Similarly, while blood pressure lowering medications may be linked to orthostatic hypotension which in turn increases the risk of falls, the benefit of good blood pressure control in terms of secondary stroke prevention outweighs the risk of falls. Until better evidence is available, the suggested management approach should then be based on local resources, and published evidence for fall prevention. Multicomponent exercise and individually tailored multifactorial interventions should still be considered as published evidence evaluating the above have included stroke patients in their study population.
Keywords: accidental falls; aged; stroke.
Conflict of interest statement
Maw Pin Tan has received honoraria as a speaker from Boerhinger Ingelheim, Novartis, Pfizer, Lundbeck, Kotrapharma and Merck, Sharpe and Dohme. She has also received travel sponsorships from Boerhinger Ingelheim and Lundbeck. Kit Mun Tan has received honoraria as a speaker, from Boerhinger Ingelheim, Pfizer and Lundbeck. She has received educational travel sponsorship from Pfizer and Lundbeck.
Figures


References
-
- Kerse N., Parag V., Feigin V.L., McNaughton H., Hackett M.L., Bennett D.A., Anderson C.S. Auckland Regional Community Stroke (ARCOS) Study Group. Falls after stroke: Results from the Auckland Regional Community Stroke (ARCOS) Study, 2002 to 2003. Stroke. 2008;39:1890–1893. doi: 10.1161/STROKEAHA.107.509885. - DOI - PubMed
-
- Callaly E.L., Ni Chroinin D., Hannon N., Sheehan O., Marnane M., Merwick A., Kelly L.A., Horgan G., Williams E., Harris D., et al. Falls and fractures 2 years after acute stroke: The North Dublin Population Stroke Study. Age Ageing. 2015;44:882–886. - PubMed